SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-151745
Filing Date
2009-07-21
Accepted
2009-07-20 21:19:16
Documents
5
Period of Report
2009-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16442
2 FORM OF NOTE AMENDMENT AND RELEASE OF COLLATERAL dex41.htm EX-4.1 19238
3 FORM OF NOTE AMENDMENT dex42.htm EX-4.2 16611
4 FORM OF LETTER AMENDMENT dex43.htm EX-4.3 13481
5 GRAPHIC g82962g27s79.jpg GRAPHIC 15701
  Complete submission text file 0001193125-09-151745.txt   89421
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33635 | Film No.: 09954045
SIC: 2836 Biological Products, (No Diagnostic Substances)